CFO Christine Mikail bought 24,000 shares of NGNE at $20.48 ($491.4K); stock down -68.8% from 52-week high, company unprofitable with $-20.2M net income.
Cvijic Christine Mikail, President and CFO, purchased 24,000 shares at $20.48 on 2024-11-22, increasing her holdings by 45.4% to 76.8K shares. This buy occurred in a difficult context: the stock trades at $22.32, down -68.8% from its 52-week high of $71.53 and -53.9% over the past 30 days. Neurogene reported $0.00 revenue in the latest quarter and a net loss of $-20.2M over its most recent full fiscal year. An insider equity purchase of this size by the CFO during a period of steep price decline and unprofitability is material and merits scrutiny of the company's forward guidance and burn rate expectations.